TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 251 filers reported holding TESARO INC in Q1 2018. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $586,000 | -82.9% | 13,181 | -78.0% | 0.00% | -85.7% |
| Q1 2018 | $3,421,000 | -58.9% | 59,866 | -40.4% | 0.01% | -64.1% |
| Q4 2017 | $8,321,000 | -11.3% | 100,404 | +38.2% | 0.04% | -18.8% |
| Q3 2017 | $9,377,000 | -5.8% | 72,636 | +2.1% | 0.05% | -17.2% |
| Q2 2017 | $9,952,000 | -2.5% | 71,154 | +7.3% | 0.06% | -30.1% |
| Q1 2017 | $10,207,000 | +174.0% | 66,338 | +139.5% | 0.08% | +207.4% |
| Q4 2016 | $3,725,000 | +256.5% | 27,699 | +165.6% | 0.03% | +285.7% |
| Q3 2016 | $1,045,000 | -76.8% | 10,430 | -80.5% | 0.01% | -80.0% |
| Q2 2016 | $4,497,000 | +1300.9% | 53,500 | +632.9% | 0.04% | +1066.7% |
| Q1 2016 | $321,000 | -60.9% | 7,300 | -53.5% | 0.00% | 0.0% |
| Q4 2015 | $821,000 | -14.7% | 15,700 | -34.6% | 0.00% | -40.0% |
| Q3 2015 | $962,000 | -87.1% | 24,000 | -81.1% | 0.01% | -88.6% |
| Q2 2015 | $7,479,000 | +73.3% | 127,200 | +69.1% | 0.04% | +33.3% |
| Q1 2015 | $4,316,000 | +749.6% | 75,200 | +359.6% | 0.03% | +560.0% |
| Q2 2014 | $508,000 | -56.2% | 16,362 | -58.4% | 0.01% | -50.0% |
| Q1 2014 | $1,160,000 | – | 39,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 9,854,255 | $565,634,000 | 25.58% |
| Perceptive Advisors | 978,359 | $56,158,000 | 4.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 556,379 | $31,936,000 | 4.05% |
| HealthCor Management, L.P. | 925,000 | $53,095,000 | 2.53% |
| Monashee Investment Management LLC | 50,000 | $2,870,000 | 1.79% |
| Cormorant Asset Management, LP | 191,250 | $10,978,000 | 1.70% |
| BB BIOTECH AG | 854,582 | $49,053,000 | 1.46% |
| HealthCor Management, L.P. | 500,000 | $28,700,000 | 1.37% |
| Rock Springs Capital Management LP | 210,000 | $12,054,000 | 1.13% |
| Orbimed Advisors | 2,057,700 | $118,112,000 | 1.01% |